Edwards Lifesciences reported $1.02B in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Atricure ATRC:US USD 58.39M 794K
Baxter International BAX:US USD 4.74B 1.04B
Becton, Dickinson and BDX:US USD 7.63B 186M
Cardiovascular Systems CSII:US USD 36.76M 394K
Cooper Companies COO:US USD 915.8M 364.4M
Cryolife CRY:US USD 49.68M 3.68M
Dexcom DXCM:US USD 1.84B 938.8M
Edwards Lifesciences EW:US USD 1.02B 104.5M
Globus Medical GMED:US USD 159.2M 13.95M
Hologic HOLX:US USD 956.2M 18.5M
Icu Medical ICUI:US USD 494.56M 5.52M
Inogen INGN:US USD 65.35M 387K
Insulet PODD:US USD 364.7M 30.5M
Integra Lifesciences IART:US USD 320.91M 16.45M
Intuitive Surgical ISRG:US USD 1.86B 628M
Masimo MASI:US USD 630M 42.7M
Medtronic MDT:US USD 14.42B 43M
Merit Medical Systems MMSI:US USD 220.64M 7.61M
Nuvasive NUVA:US USD 716.05M 18.64M
Stryker SYK:US USD 6.3B 1.73B
Tandem Diabetes Care TNDM:US USD 165.29M 8.34M
Teleflex TFX:US USD 581.49M 29.45M
Zimmer Biomet Holdings Inc ZBH:US USD 2.36B 62.5M